Aortic valve replacement devices market: Trend, Size and Growth (2025-2034)

Market Overview

Aortic valve replacement (AVR) is a critical procedure used to treat individuals suffering from severe aortic valve diseases such as stenosis and regurgitation. These conditions significantly impact the heart’s ability to pump blood efficiently, which can lead to severe complications and even death if left untreated. The aortic valve replacement devices market is an essential segment within the cardiovascular device market, facilitating improved patient outcomes and reduced mortality rates. As the prevalence of aortic valve disease increases with the aging global population, the demand for these devices is expected to grow, propelling market growth during the forecast period from 2025 to 2034.

Market Size and Share

The aortic valve replacement devices market reached a value of approximately USD 8.99 billion in 2024. This market is projected to grow at a compound annual growth rate (CAGR) of 6.50% from 2025 to 2034, with the total market size reaching USD 16.88 billion by 2034. The significant market growth is driven by the increasing prevalence of aortic valve diseases, the development of minimally invasive techniques, and technological advancements in valve devices. Moreover, the shift toward less invasive surgeries and improved patient outcomes continue to influence the market positively.

Market Trends

Technological Advancements in Valve Devices
Recent technological advancements are revolutionizing the aortic valve replacement market. The development of transcatheter aortic valve replacement (TAVR) devices has significantly improved the treatment outcomes for patients with aortic valve diseases. These devices are particularly beneficial for high-risk patients who cannot undergo traditional open surgery. Additionally, continuous improvements in valve material and design have enhanced the durability and biocompatibility of these devices, making them more effective in long-term use.
Minimally Invasive Surgical Procedures
Minimally invasive surgery is a growing trend in the aortic valve replacement market. Transcatheter aortic valve implantation (TAVI), a minimally invasive procedure, offers many advantages over open surgery, such as faster recovery times, fewer complications, and shorter hospital stays. The increasing adoption of minimally invasive techniques is driven by the growing demand for safer and more efficient procedures, especially among elderly patients. This shift is significantly contributing to the market’s growth.
Increasing Prevalence of Heart Valve Diseases
The global rise in cardiovascular diseases, particularly in the aging population, is a major driver of the aortic valve replacement devices market. Conditions such as aortic stenosis, where the aortic valve becomes narrowed and obstructs blood flow, are becoming more common as the population ages. As a result, there is an increasing demand for effective treatments, including aortic valve replacement procedures. This growing burden of heart diseases is expected to fuel the demand for AVR devices.
Preference for Personalized Medicine
Personalized medicine is gaining momentum in the aortic valve replacement market, with more healthcare providers focusing on individualized treatment plans for patients. Customizable valve devices that cater to the specific anatomical features of each patient are becoming more prevalent. Personalized treatment plans help optimize outcomes and reduce the risk of complications. The trend toward personalized medicine is expected to continue influencing the market as healthcare providers seek more effective and patient-centric solutions.

Get a free sample request: https://www.expertmarketresearch.com/reports/aortic-valve-replacement-devices-market/requestsample

Market Analysis

Breakup by Surgery Type
The market for aortic valve replacement devices is divided into two primary surgery types: open surgery and minimally invasive surgery. Open surgery, traditionally the standard approach, involves more extensive procedures and longer recovery times. However, minimally invasive surgeries, such as TAVR, are gaining popularity due to their reduced recovery time, fewer complications, and better outcomes for high-risk patients. As a result, minimally invasive procedures are expected to dominate the market in the coming years.
Breakup by Product Type
The two major product types in the aortic valve replacement devices market are transcatheter aortic valve devices and sutureless aortic valve replacement (SUAVR) devices. Transcatheter aortic valves are typically used in TAVR procedures and are preferred for high-risk patients who cannot undergo open surgery. On the other hand, sutureless aortic valve replacement devices are used in cases where suturing may not be necessary, offering shorter procedure times and better surgical outcomes. These products are expected to continue to evolve and dominate the market.
Breakup by End User
The major end users of aortic valve replacement devices include hospitals, ambulatory surgical centers, and other healthcare facilities. Hospitals are the primary end-users of these devices, as they are equipped to handle complex surgeries. Ambulatory surgical centers are becoming an increasingly important segment, driven by the growing demand for minimally invasive procedures that can be performed on an outpatient basis. This trend is expected to boost the growth of ambulatory centers and increase their share in the market.
Breakup by Region
The aortic valve replacement market is segmented by region into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America, particularly the United States, is expected to maintain its dominance in the market due to advanced healthcare infrastructure, widespread adoption of minimally invasive procedures, and strong reimbursement systems. Europe also holds a significant share of the market, driven by increasing cardiovascular disease rates and advanced medical technology. The Asia Pacific region is expected to experience the highest growth, supported by improving healthcare infrastructure and rising awareness of cardiovascular health.

Regional Insights

North America
North America is the largest market for aortic valve replacement devices, with the United States contributing significantly to market growth. The region benefits from a well-established healthcare system, advanced medical technologies, and strong patient demand for minimally invasive procedures. With a large aging population and increasing cardiovascular disease prevalence, the demand for aortic valve replacement devices continues to rise. Furthermore, favorable reimbursement policies and the presence of leading medical device manufacturers support the region’s market dominance.
Asia Pacific
Asia Pacific is expected to see rapid growth in the aortic valve replacement market due to the increasing prevalence of heart diseases, expanding healthcare infrastructure, and rising awareness of cardiovascular health. Countries such as China, Japan, and India are experiencing significant improvements in healthcare access, which is driving the adoption of advanced medical technologies, including aortic valve replacement devices. With a large population base and an increasing elderly population, the Asia Pacific market is projected to grow at the fastest rate during the forecast period.

Market Growth

The aortic valve replacement devices market is growing due to several key factors. The aging global population is one of the primary drivers, as older adults are more prone to aortic valve diseases such as aortic stenosis and regurgitation. Technological advancements in valve design and surgical techniques, particularly transcatheter aortic valve replacement (TAVR), are making procedures safer and less invasive. Additionally, the shift toward minimally invasive surgeries and the rising demand for more personalized treatment options are further driving market expansion. The ongoing research and development efforts to improve device longevity and biocompatibility will also contribute to future market growth.

Recent Developments Challenges

Innovations in Valve Technology
Recent innovations in aortic valve replacement devices include the development of more durable and biocompatible materials. These advancements have led to improved device longevity and better long-term outcomes for patients. Newer self-expanding and balloon-expandable valve devices are also being developed to reduce surgical time and improve patient recovery. These innovations are enhancing the overall effectiveness of the procedure and driving market growth.
Regulatory Approvals and Market Access
The approval process for aortic valve replacement devices can be lengthy, with manufacturers needing to comply with stringent regulatory requirements set by agencies such as the FDA and the European Medicines Agency (EMA). While regulatory approvals are essential for ensuring safety and efficacy, delays in approval processes can hinder the timely introduction of new products to the market.
Challenges in Emerging Markets
Although developed markets are witnessing robust growth, emerging markets face challenges related to high device costs, limited healthcare infrastructure, and lower awareness of advanced heart valve treatments. These barriers restrict access to advanced aortic valve replacement technologies in low-income regions. However, as healthcare access improves and the demand for heart disease treatments rises, these markets are expected to grow in the long term.
Increasing Patient Demand for Less Invasive Procedures
As more patients seek less invasive treatment options, the demand for minimally invasive aortic valve replacement procedures continues to grow. However, the availability of trained medical professionals and advanced medical facilities capable of performing these procedures remains a challenge in certain regions. This could limit the overall adoption of minimally invasive surgeries in some areas.

Key Players

Boston Scientific Corporation
Boston Scientific Corporation is a leader in the aortic valve replacement market, particularly in the field of transcatheter aortic valve implantation (TAVI) devices. The company’s expertise in cardiovascular devices has positioned it at the forefront of the market. Its TAVR systems, such as the WATCHMAN device, are widely used and continue to undergo improvements to enhance patient outcomes. Boston Scientific’s focus on innovation, research, and global expansion keeps it a key player in the market.
Corcym S.r.l.
Corcym S.r.l. is a prominent player in the aortic valve replacement market, offering advanced TAVR devices. The company is known for its commitment to research and development, continuously improving the performance of its heart valve devices. Corcym’s products are designed to provide optimal patient outcomes while minimizing surgical risks, making them increasingly popular among healthcare providers.
Edwards Lifesciences Corporation
Edwards Lifesciences Corporation is another significant contributor to the global aortic valve replacement market. The company’s Sapien TAVR device is widely recognized as a leader in the field, offering patients a less invasive alternative to open-heart surgery. Edwards Lifesciences continues to innovate in the field of heart valve replacement, expanding its product portfolio to meet the growing demand for advanced valve technologies.
Medtronic plc
Medtronic plc is one of the largest medical device companies in the world and a major player in the aortic valve replacement market. The company’s Evolut TAVR system has been instrumental in transforming the treatment of aortic valve diseases. Medtronic’s global presence and strong research and development capabilities position it as a key competitor in the aortic valve replacement market.

Other

key players include Artivion, Inc., Abbott Laboratories, and several other manufacturers that contribute to the ongoing development of aortic valve replacement technologies.

FAQs

What is aortic valve replacement surgery?
Aortic valve replacement surgery involves replacing a diseased or damaged aortic valve with a prosthetic valve. This can be done via traditional open surgery or through minimally invasive techniques like TAVR.
What are the types of aortic valve replacement devices?
The two main types are transcatheter aortic valve devices (TAVR) and sutureless aortic valve replacement (SUAVR) devices.
What factors are driving the growth of the aortic valve replacement market?
Key factors include the aging population, the increasing prevalence of heart valve diseases, technological advancements, and the shift toward minimally invasive surgical techniques.
Which regions are leading the aortic valve replacement market?
North America and Europe are the leading regions, while Asia Pacific is expected to experience the fastest growth due to improving healthcare infrastructure and rising cardiovascular disease rates.